Graham Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Buy |
+39,260
| New | +$250K | ﹤0.01% | 1014 |
|
|
2024
Q4 | – | Sell |
-36,692
| Closed | -$306K | – | 1267 |
|
|
2024
Q3 | $306K | Sell |
36,692
-7,183
| -16% | -$60K | 0.01% | 741 |
|
|
2024
Q2 | $299K | Buy |
+43,875
| New | +$299K | 0.01% | 707 |
|
|
2024
Q1 | – | Sell |
-36,637
| Closed | -$87.9K | – | 1102 |
|
|
2023
Q4 | $87.9K | Buy |
36,637
+23,986
| +190% | +$57.6K | ﹤0.01% | 888 |
|
|
2023
Q3 | $43K | Buy |
+12,651
| New | +$43K | ﹤0.01% | 954 |
|
|
2022
Q3 | – | Sell |
-6,626
| Closed | -$205K | – | 1109 |
|
|
2022
Q2 | $205K | Sell |
6,626
-4,493
| -40% | -$139K | 0.01% | 912 |
|
|
2022
Q1 | $456K | Buy |
+11,119
| New | +$456K | 0.02% | 576 |
|